Search - tctmd.com

Displaying 41 - 60 of 66

Sort: Relevancy | Date

News Opinion CV Team Dispatch

September 2021 News Roundup

L.A. McKeown

September 01, 2021

News Features

Roughly 80% of ESC Guideline Writers Have Financial COIs

Michael O'Riordan

April 01, 2021

Excluded from Pivotal Trials, Low-risk Complex Patients Warrant Caution

News Daily News

Excluded From Pivotal Trials, Low-risk Complex AS Patients Warrant Caution

L.A. McKeown

January 22, 2021

News Daily News

High TEE Injury Rate in Structural Heart Interventions Warrants Caution

Yael L. Maxwell

June 24, 2020

News Daily News

Transcatheter Tricuspid, Mitral Repair Appear Safe to Combine: Registry Data

Caitlin E. Cox

January 20, 2020

News Daily News

Cardiac Rehab Tied to Fewer Hospitalizations, Deaths After Valve Surgery

Todd Neale

October 23, 2019

News Conference News TCT 2019

Transcatheter Options Best for Tricuspid Regurgitation in Matched Registry Analysis

Michael O'Riordan

September 27, 2019

News Opinion Editor's Corner TCT 2019

TCT 2019 Day Two: Transcatheter Valves, New and Old

Shelley Wood

September 27, 2019

News Industry News

Abbott Launches World's First Pivotal Trial To Test New Approach For Repairing Leaky Tricuspid Heart Valves

September 05, 2019

News Conference News TVT 2019

Pascal Transcatheter Device Safe, Improves Tricuspid Regurgitation: Early Results

Shelley Wood

June 19, 2019

News Conference News EuroPCR 2019

Clip-Based Tricuspid Repair Improves Regurgitation, Function, and Quality of Life: TRILUMINATE

Michael O'Riordan

May 22, 2019

News Daily News

‘We Have to Go to Them’: New Global Initiative for Treating Rheumatic Heart Disease

Michael O'Riordan

August 06, 2018

News Daily News

Isolated Tricuspid Valve Surgery Remains Rare and Risky

Caitlin E. Cox

December 13, 2017

News Conference News TCT 2017

For ‘Torrential’ Tricuspid Regurgitation, Two New Transcatheter Devices Safe, Effective in Early Results

Yael L. Maxwell

November 02, 2017

News Industry News

Micro Interventional Devices, Inc.™ Completes First Clinical Tricuspid Bicuspidization Procedure Utilizing MIA™ Technology

September 07, 2017

News Industry News

NaviGate Cardiac Structures Inc. (“NCSI”) reports world’s first successful transcatheter implantation of 52-mm tricuspid valve into a transplanted-heart patient to correct “torrential” tricuspid regurgitation (TR)

August 30, 2017

News Conference News ESC 2017

European Societies Issue New Valvular Heart Disease Guidelines, With Important Shifts

Shelley Wood

August 27, 2017

News Daily News

NeuroARC Proposes New Standards for Assessing Neurologic Damage in CV Clinical Trials

Caitlin E. Cox

February 07, 2017

News Industry News

First Ever Venus P-Valve Implantations in Latin America

April 06, 2016

News Daily News

Sapien 是经导管肺动脉瓣置换的“可行、持久”方案

Michael O'Riordan

December 27, 2015

Advertisement

September 2021 News Roundup

Roughly 80% of ESC Guideline Writers Have Financial COIs

Excluded From Pivotal Trials, Low-risk Complex AS Patients Warrant Caution

High TEE Injury Rate in Structural Heart Interventions Warrants Caution

Transcatheter Tricuspid, Mitral Repair Appear Safe to Combine: Registry Data

Cardiac Rehab Tied to Fewer Hospitalizations, Deaths After Valve Surgery

Transcatheter Options Best for Tricuspid Regurgitation in Matched Registry Analysis

TCT 2019 Day Two: Transcatheter Valves, New and Old

Abbott Launches World's First Pivotal Trial To Test New Approach For Repairing Leaky Tricuspid Heart Valves

Pascal Transcatheter Device Safe, Improves Tricuspid Regurgitation: Early Results

Clip-Based Tricuspid Repair Improves Regurgitation, Function, and Quality of Life: TRILUMINATE

‘We Have to Go to Them’: New Global Initiative for Treating Rheumatic Heart Disease

Isolated Tricuspid Valve Surgery Remains Rare and Risky

For ‘Torrential’ Tricuspid Regurgitation, Two New Transcatheter Devices Safe, Effective in Early Results

Micro Interventional Devices, Inc.™ Completes First Clinical Tricuspid Bicuspidization Procedure Utilizing MIA™ Technology

NaviGate Cardiac Structures Inc. (“NCSI”) reports world’s first successful transcatheter implantation of 52-mm tricuspid valve into a transplanted-heart patient to correct “torrential” tricuspid regurgitation (TR)

European Societies Issue New Valvular Heart Disease Guidelines, With Important Shifts

NeuroARC Proposes New Standards for Assessing Neurologic Damage in CV Clinical Trials

First Ever Venus P-Valve Implantations in Latin America

Sapien 是经导管肺动脉瓣置换的“可行、持久”方案

Advertisement

Advertisement

Sign In

Forgot Your Password?

Search TCTMD

CME TITLE

Sign up for our newsletter

Search TCTMD

Submit an Event

Become a PREMIUM MEMBER or LOG IN to view exclusive content

REGISTER for free or LOG IN to view this content